Medical experts gather in Lianyungang to discuss the path of industrial innovation and development

According to Cao Weidong, member of the Standing Committee of Lianyungang Municipal Committee and Secretary of the Party Working Committee of the Development Zone, "the new pharmaceutical industry is a leading industry with characteristics, vitality and competitiveness in Lianyungang Development Zone With less than 1 / 10 of resources, it has created 1 / 3 of the output value, contributed nearly 1 / 2 of the tax revenue and driven 3 / 4 of the R & D investment." How can China's pharmaceutical industry realize real innovation? How can the R & D and production of pharmaceutical enterprises connect with the international? At the 2017 Jinqiu economic and Trade Fair of Lianyungang Economic and Technological Development Zone, which opened on the 14th, the professional forum held with the theme of "innovative development path of pharmaceutical industry in the new situation" attracted professionals from all walks of life, including politics, industry, education, research and enterprises Pharmaceutical industry is an internationally recognized sunrise industry Its development is not only related to people's health and well-being, but also the embodiment of a country and a region's comprehensive economic strength and technological innovation ability According to Mo Zongtong, director of the food and Drug Administration of Jiangsu Province, at present, Lianyungang, Taizhou, suxichang and Nanjing have formed four distinctive medical plates in the province, which not only achieve scale benefits, but also form a complete industrial chain However, Mo Zongtong also pointed out the problems faced by the development of Jiangsu pharmaceutical industry "Our industrial development mode needs to be transformed, industrial structure needs to be optimized, enterprises and products with international competitiveness are not enough, and investment in R & D funds needs to be increased." He proposed that the industry should continue to promote reform, improve relevant policies for industrial development, and enterprises should vigorously introduce talents and technology The process of new drug research and development is very complex From the germination of ideas to the successful marketing of drugs, there is not only a huge risk of failure, even if it is made, it will take 10 years or even longer According to Cao Guoqing, deputy general manager of Jiangsu Hengrui Pharmaceutical Co., Ltd., although drug R & D is difficult, policy support is very important for the industry, and the more important cornerstone is the development of national economy, which will promote the return of more talents and broaden the market "The spring of the industry is coming, and we can't imagine a better environment." Cao Guoqing laments that the dividend of the policy allows the industry to achieve a breakthrough Innovative drugs can improve the core competitiveness of enterprises, but the difficulty and uncertainty of R & D process make many enterprises flinch In this regard, Zhang Tianyi, general manager of Fangda Pharmaceutical (China) Co., Ltd., believes that in the face of practical problems such as high labor cost investment and incomplete technical experience, pharmaceutical enterprises can try to control costs and shorten the R & D cycle by outsourcing R & D services "Multinational pharmaceutical companies have seen layoffs in recent two years Many companies have closed their R & D centers in China, but this does not mean that their R & D speed has slowed down, but that their strategies have changed." He said that these companies have changed their traditional R & D mode and have turned to cooperate with small R & D enterprises and universities "The new pharmaceutical industry is a leading industry with characteristics, vitality and competitiveness in Lianyungang Development Zone With less than 1 / 10 of resources, it has created 1 / 3 of the output value, contributed nearly 1 / 2 of the tax revenue, and driven 3 / 4 of the R & D investment." Cao Weidong, member of the Standing Committee of Lianyungang Municipal Party committee and Secretary of the Party Working Committee of the Development Zone, introduced that the purpose of holding this forum is to make suggestions and determine the development of the new pharmaceutical industry in the new situation with your unique professional perspective and rich industry practice At the same time, we also hope to build the new pharmaceutical industry forum into a common "circle of friends", where we can collide wisdom, seek business opportunities and achieve win-win results Former title: medical experts gather in Lianyungang to discuss industrial innovation in the new situation reporter: Gu Shushu